Extracellular vesicles derived from TNF-α-preconditioned mesenchymal stem cells mitigate inflammatory retinal injury

Abstract

Aim: To evaluate the therapeutic efficacy and mechanisms of tumor necrosis factor-alpha (TNF-α) preconditioned mesenchymal stem cells (MSCs)-derived small extracellular vesicles (hereafter abbreviated as T-sEV), along with the control small extracellular vesicles (sEV, representing vesicles from naive/unstimulated MSCs), in mitigating inflammatory retinal injury.

Methods: T-sEV were isolated from TNF-α-preconditioned MSCs and systematically characterized. Small RNA sequencing was performed to identify the microRNA (miRNA) cargo of T-sEV. The effect of T-sEV on lipopolysaccharide (LPS)-induced M1 macrophage polarization was assessed by flow cytometry. Integrated bioinformatic analysis linked T-sEV miRNAs to macrophage transcriptome changes. T-sEV were administered intravitreally in a murine sodium iodate (NaIO₃)-induced retinal degeneration model. Electroretinography (ERG), optical coherence tomography (OCT), flow cytometry, intraocular pressure (IOP) and systemic examinations were conducted.

Results: T-sEV exhibited an enrichment of anti-inflammatory miRNAs, notably miR-146a-5p. They were efficiently internalized by macrophages, significantly suppressing M1 polarization, as evidenced by the decreased percentage of cluster of differentiation (CD)11b⁺/CD86⁺ cells (29.60% ± 2.30%) compared to the sEV group (34.90% ± 1.57%, P < 0.05). Analysis showed T-sEV miRNAs targeted and downregulated key pro-inflammatory genes such as Cd86 and Il1r1. In vivo, T-sEV treatment significantly preserved retinal a- and b-wave amplitudes and structural integrity. T-sEV treatment markedly reduced retinal macrophage infiltration, decreasing the proportion of F4/80⁺CD11b⁺ cells to 0.38% ± 0.13%, significantly lower than in the sEV group (1.66% ± 0.47%, P < 0.01). No adverse effects on IOP or systemic markers were observed.

Conclusion: TNF-α preconditioning enhances MSC-derived sEV therapeutic capacity by enriching their anti-inflammatory miRNAs. T-sEV suppress pro-inflammatory macrophage activation and provide superior neuroprotection in a retinal degeneration model, indicating a safe and promising cell-free therapeutic strategy.

Keywords

TNF-α / mesenchymal stem cell / small extracellular vesicles / sEV-derived miRNAs / inflammatory retinal injury

References

[1] Nita M,Ascaso FJ.Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation).Mediators Inflamm.2014;2014:930671 PMCID:PMC4152952

[2] Zou M,Nie Q.Inhibition of cGAS-STING by JQ1 alleviates oxidative stress-induced retina inflammation and degeneration.Cell Death Differ.2022;29:1816-33 PMCID:PMC9433402

[3] Jaffe GJ,Csaky KG.C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial.Ophthalmology.2021;128:576-86

[4] Hanus J,Wang S.RPE necroptosis in response to oxidative stress and in AMD.Ageing Res Rev.2015;24:286-98 PMCID:PMC4661094

[5] Kumar-Singh R.The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials.Exp Eye Res.2019;184:266-77

[6] Cabral de Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions.Br J Ophthalmol.2022;106:297-304 PMCID:PMC8867261

[7] Asgari Taei A, Khodabakhsh P, Nasoohi S, Farahmandfar M, Dargahi L. Paracrine effects of mesenchymal stem cells in ischemic stroke: opportunities and challenges.Mol Neurobiol.2022;59:6281-306

[8] Fu X,Halim A,Luo Q.Mesenchymal stem cell migration and tissue repair.Cells.2019;8:784 PMCID:PMC6721499

[9] Huang X,Huang J.Human amnion mesenchymal stem cells promote endometrial repair via paracrine, preferentially than transdifferentiation.Cell Commun Signal.2024;22:301 PMCID:PMC11140932

[10] Tan F,Wang Z,Shahzad K.Clinical applications of stem cell-derived exosomes.Signal Transduct Target Ther.2024;9:17 PMCID:PMC10784577

[11] Lotfy A,Wang H.Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials.Stem Cell Res Ther.2023;14:66 PMCID:PMC10079493

[12] Keshtkar S,Ghahremani MH.Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine.Stem Cell Res Ther.2018;9:63 PMCID:PMC5845209

[13] Kletukhina S,Titova A.Role of mesenchymal stem cells and extracellular vesicles in idiopathic pulmonary fibrosis.Int J Mol Sci.2022;23:11212 PMCID:PMC9569825

[14] Ding Z,Yuan X.Apoptotic extracellular vesicles derived from hypoxia-preconditioned mesenchymal stem cells within a modified gelatine hydrogel promote osteochondral regeneration by enhancing stem cell activity and regulating immunity.J Nanobiotechnol.2024;22:74 PMCID:PMC10885680

[15] Tian J,Xiong Y.Small extracellular vesicles derived from hypoxic preconditioned dental pulp stem cells ameliorate inflammatory osteolysis by modulating macrophage polarization and osteoclastogenesis.Bioact Mater.2023;22:326-42 PMCID:PMC9587346

[16] Zazeckyte G,Vilkeviciute A.Associations of tumor necrosis factor-alpha gene polymorphisms (TNF)-α TNF-863A/C (rs1800630), TNF-308A/G (rs1800629), TNF-238A/G (rs361525), and TNF-alpha serum concentration with age-related macular degeneration.Life.2022;12:928 PMCID:PMC9319996

[17] Ridley RB,Lee J.Modulation of retinal inflammation delays degeneration in a mouse model of geographic atrophy.Sci Rep.2025;15:30153 PMCID:PMC12358612

[18] Olivares-González L,Campillo I.Retinal inflammation, cell death and inherited retinal dystrophies.Int J Mol Sci.2021;22:2096 PMCID:PMC7924201

[19] Veerasubramanian PK,Quan J.Targeting TNF/TNFR superfamilies in immune-mediated inflammatory diseases.J Exp Med.2024;221:e20240806 PMCID:PMC11413425

[20] Jang DI,Shin HY.The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics.Int J Mol Sci.2021;22:2719 PMCID:PMC7962638

[21] Nakao Y,Zhang Q.Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss.Acta Biomater.2021;122:306-24 PMCID:PMC7897289

[22] Li J,Wang J.Dendritic cell repression by TNF-α-primed exosomes accelerate T2DM wound healing through miR-146a-5p/TXNIP/NLRP3 axis.Int J Nanomedicine.2025;20:9963-80 PMCID:12363982

[23] Mead B,Zack DJ,Tomarev S.TNFα-mediated priming of mesenchymal stem cells enhances their neuroprotective effect on retinal ganglion cells.Invest Ophthalmol Vis Sci.2020;61:6 PMCID:PMC7324256

[24] Liang YC,Li XD.TNF-α-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture.J Cell Physiol.2019;234:23243-55

[25] Tang Y,Zhang X.Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration.J Control Release.2023;357:356-70

[26] Yu Z,Jiang N.TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis.Biomaterials.2022;284:121484

[27] Wu J,Xiang W.Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis.J Nanobiotechnol.2024;22:555 PMCID:PMC11391629

[28] Enzbrenner A,Biber J.Sodium iodate-induced degeneration results in local complement changes and inflammatory processes in murine retina.Int J Mol Sci.2021;22:9218 PMCID:PMC8431125

[29] Anderson BD,Bell BA,Dunaief JL.Optimizing the sodium iodate model: effects of dose, gender, and age.Exp Eye Res.2024;239:109772 PMCID:PMC10922497

[30] Liu J,Yu J.MiR-146a-5p engineered hucMSC-derived extracellular vesicles attenuate Dermatophagoides farinae-induced allergic airway epithelial cell inflammation.Front Immunol.2024;15:1443166 PMCID:PMC11446808

[31] Lv Q,Tian W.Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis.J Nanobiotechnol.2023;21:419 PMCID:PMC10641965

[32] Chen X,Chen T.miR-146a-5p promotes epithelium regeneration against LPS-induced inflammatory injury via targeting TAB1/TAK1/NF-κB signaling pathway.Int J Biol Macromol.2022;221:1031-40

[33] Zhang J,Zhao G.Mesenchymal stem cell-derived extracellular vesicles protect retina in a mouse model of retinitis pigmentosa by anti-inflammation through miR-146a-Nr4a3 axis.Stem Cell Res Ther.2022;13:394 PMCID:PMC9351183

[34] Turano E,Virla F,Mariotti R.Extracellular vesicles from mesenchymal stem cells: towards novel therapeutic strategies for neurodegenerative diseases.Int J Mol Sci.2023;24:2917 PMCID:PMC9917806

[35] Zhu Y,Xue Z,Chen X.Mesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies.J Transl Med.2025;23:364 PMCID:PMC11934660

[36] Zou J,Cui W.Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing.J Nanobiotechnol.2023;21:14 PMCID:9841717

[37] Zhou H,Zhou T.IL-23 priming enhances the neuroprotective effects of MSC-derived exosomes in treating retinal degeneration.Invest Ophthalmol Vis Sci.2024;65:8 PMCID:PMC11309046

[38] François M,Li M.Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.Mol Ther.2012;20:187-95

[39] Tai TS,Yang YS.IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity.Br J Cancer.2025;132:126-36 PMCID:PMC11723913

[40] Tong Y,Ma J.Comparative mechanistic study of RPE cell death induced by different oxidative stresses.Redox Biol.2023;65:102840 PMCID:PMC10440584

[41] Becker S,Jones BW,McDonnell FS.Modeling complex age-related eye disease.Prog Retin Eye Res.2024;100:101247 PMCID:PMC11268458

[42] Zhang Y,Huang J,Du S.Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications.Int J Nanomedicine.2020;15:6917-34 PMCID:7519827

[43] Duval C,Tsang BK.Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review.J Ovarian Res.2024;17:160 PMCID:PMC11302210